0001193125-22-157530.txt : 20220523 0001193125-22-157530.hdr.sgml : 20220523 20220523163933 ACCESSION NUMBER: 0001193125-22-157530 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220523 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Calithera Biosciences, Inc. CENTRAL INDEX KEY: 0001496671 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272366329 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36644 FILM NUMBER: 22952303 BUSINESS ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-870-1000 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 8-K 1 d306255d8k.htm 8-K 8-K
false 0001496671 --12-31 0001496671 2022-05-23 2022-05-23

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 23, 2022

 

 

Calithera Biosciences, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36644   27-2366329

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

343 Oyster Point Blvd., Suite 200

South San Francisco, California

  94080
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (650) 870-1000

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $0.0001 par value   CALA   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 1.01 Entry into a Material Definitive Agreement.

Amendment to Asset Purchase Agreement

On October 18, 2021, Calithera Biosciences, Inc., entered into an Asset Purchase Agreement, or the APA, with Millennium Pharmaceuticals, Inc., or Millennium, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, or Takeda, pursuant to which we acquired or licensed from Millennium certain technology, intellectual property and other assets related to Takeda’s small molecule programs TAK-228 and TAK-659.

On May 23, 2022, Calithera and Millennium entered into the Amendment to the APA to amend the amount of the deductibles under Section 9.4.1 and Schedule 1.1(c) (Materials).

The foregoing is only a brief description of the Amendment to the APA and is qualified in its entirety by reference to the Amendment to the APA, which we intend to file as an exhibit to our Quarterly Report on Form 10-Q for the quarter ending June 30, 2022.

The APA is filed as Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, filed with the Securities and Exchange Commission on November 9, 2021.

Item 3.03 Material Modifications to Rights of Security Holders

Certificate of Amendment to Certificate of Designations

On October 18, 2021, in connection with the APA and the sale and issuance of Series A Convertible Preferred Stock to Millennium pursuant to that certain Preferred Stock Purchase Agreement, dated October 18, 2021, or the Stock Purchase Agreement, we filed a Certificate of Designations of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock with the Secretary of State of the State of Delaware, or the Certificate of Designations, designating 1,000,000 shares of Series A Preferred Stock with an original issue price of $35.00 per share, which became effective with the Secretary of State of the State of Delaware upon filing.

On May 23, 2022, we filed a Certificate of Amendment to the Certificate of Designations, or the Certificate of Amendment, which limits the aggregate number of shares of common stock to be issued upon conversion of the Series A Convertible Preferred Stock to a maximum of 132,880,282 shares of common stock (subject to adjustment in the event of a stock split, stock dividend, combination or other proportionate adjustment).

The foregoing is only a brief description of the Certificate of Amendment and is qualified in its entirety by reference to the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K, and incorporated by reference herein.

The Stock Purchase Agreement and Certificate of Designations are filed as Exhibits 10.1 and 3.1, respectively, to our Current Report on Form 8-K, filed with the Securities and Exchange Commission on October 19, 2021.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year

The description of the Certificate of Amendment in Item 3.03 above is incorporated by reference into this Item 5.03.


Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.
  

Description

3.1    Certificate of Amendment to Certificate of Designations of Preferences, Rights and Limitations of Series A Convertible Preferred Stock
104    Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 23, 2022     Calithera Biosciences, Inc.
    By:  

/S/ SUSAN M. MOLINEAUX, PH.D.

      Susan M. Molineaux, Ph.D.
      President and Chief Executive Officer
EX-3.1 2 d306255dex31.htm EX-3.1 EX-3.1

Exhibit 3.1

CERTIFICATE OF AMENDMENT

TO THE

CERTIFICATE OF DESIGNATIONS OF PREFERENCES,

RIGHTS AND LIMITATIONS

OF

SERIES A CONVERTIBLE PREFERRED STOCK

OF

CALITHERA BIOSCIENCES, INC.

Calithera Biosciences, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “DGCL”), DOES HEREBY CERTIFY:

FIRST:    That the original Certificate of Designations of Preferences, Rights and Limitations of Series A Convertible Preferred Stock (the “Series A Preferred Stock”) of the Corporation (the “Certificate of Designations”) was originally filed with the Secretary of State of the State of Delaware on October 18, 2021.

SECOND:    The Board of Directors of the Corporation, in accordance with the provisions of Sections 141(f) and 242 of the DGCL, adopted resolutions with the effect of approving and adopting this Certificate of Amendment to the Certificate of Designations (the “Certificate of Amendment”) and authorizing and directing the officers of the Corporation, for and on behalf of the Corporation, to execute and file this Certificate of Amendment with the Secretary of State of the State of Delaware.

THIRD:    That Section 8 is hereby amended to add a new Section 8.7, as follows:

“8.7 Maximum Shares Issuable Upon Conversion. Notwithstanding anything to the contrary contained herein, the maximum number of shares of Common Stock to be issued upon the conversion of the Series A Preferred Stock shall not exceed 132,880,282 shares (subject to adjustment in the event of a stock split, stock dividend, combination or other proportionate adjustment).”

FOURTH:    This Certificate of Amendment shall become effective upon filing with the Secretary of State of the State of Delaware.

FIFTH:    This Certificate of Amendment was submitted to the sole stockholder of the Series A Preferred Stock and was duly adopted and approved in accordance with the provisions of Section 242 of the General Corporate Law of the State of Delaware via written consent.

[Remainder of page intentionally left blank]


IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its officer thereunto duly authorized this 23rd day of May, 2022.

 

CALITHERA BIOSCIENCES, INC.
By:  

/s/ SUSAN M. MOLINEAUX, PH.D.

Name: Susan M. Molineaux, Ph.D.
Title: President and Chief Executive Officer

[SIGNATURE PAGE TO AMENDMENT TO CERTIFICATE OF DESIGNATIONS]

EX-101.SCH 3 cala-20220523.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 cala-20220523_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 cala-20220523_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
May 23, 2022
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001496671
Current Fiscal Year End Date --12-31
Document Type 8-K
Document Period End Date May 23, 2022
Entity Registrant Name Calithera Biosciences, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-36644
Entity Tax Identification Number 27-2366329
Entity Address, Address Line One 343 Oyster Point Blvd.
Entity Address, Address Line Two Suite 200
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code (650)
Local Phone Number 870-1000
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value
Trading Symbol CALA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 7 d306255d8k_htm.xml IDEA: XBRL DOCUMENT 0001496671 2022-05-23 2022-05-23 false 0001496671 --12-31 8-K 2022-05-23 Calithera Biosciences, Inc. DE 001-36644 27-2366329 343 Oyster Point Blvd. Suite 200 South San Francisco CA 94080 (650) 870-1000 false false false false Common Stock, $0.0001 par value CALA NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d306255d8k.htm cala-20220523.xsd cala-20220523_lab.xml cala-20220523_pre.xml d306255dex31.htm http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d306255d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d306255d8k.htm" ] }, "labelLink": { "local": [ "cala-20220523_lab.xml" ] }, "presentationLink": { "local": [ "cala-20220523_pre.xml" ] }, "schema": { "local": [ "cala-20220523.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "cala", "nsuri": "http://www.calithera.com/20220523", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d306255d8k.htm", "contextRef": "duration_2022-05-23_to_2022-05-23", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d306255d8k.htm", "contextRef": "duration_2022-05-23_to_2022-05-23", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.calithera.com//20220523/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001193125-22-157530-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-157530-xbrl.zip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